Document is current
Any future updates will be listed below
-
Authors
Kishk, Omayma A. https://orcid.org/0000-0001-8057-8862
Kim, Ivone https://orcid.org/0000-0002-2144-4861
Cheng, Carmen https://orcid.org/0000-0002-1151-7393
Summan, Mukesh
Muñoz, Monica A. https://orcid.org/0000-0001-9754-1986
- License Information
-
More Information
Article History
Received: 3 October 2023
Revised: 12 February 2024
Accepted: 29 February 2024
First Online: 11 March 2024
Declarations
:
: Because this work reflects the FDA’s ongoing public health safety surveillance for drug and biologic products, institutional review board approval was not needed.
: The authors declare no competing interests.
: This article reflects the views of the authors and should not necessarily be construed to represent Food and Drug Administration’s views or policies.
